BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31757677)

  • 1. γ-Glutamyl cyclotransferase contributes to endometrial carcinoma malignant progression and upregulation of PD-L1 expression during activation of epithelial-mesenchymal transition.
    Xu S; Yang Y; Wang X; Liu X; Jin C; Ma M; Wu S; Li Y
    Int Immunopharmacol; 2020 Apr; 81():106039. PubMed ID: 31757677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of γ-glutamyl cyclotransferase as a therapeutic target for colorectal cancer based on the lentivirus-mediated system.
    Dong J; Zhou Y; Liao Z; Huang Q; Feng S; Li Y
    Anticancer Drugs; 2016 Nov; 27(10):1011-20. PubMed ID: 27500968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer.
    Imai D; Yoshizumi T; Okano S; Itoh S; Ikegami T; Harada N; Aishima S; Oda Y; Maehara Y
    J Surg Res; 2019 Aug; 240():115-123. PubMed ID: 30927618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts.
    Ii H; Kasahara Y; Yamaguma H; Kageyama S; Kawauchi A; Obika S; Nakata S
    Anticancer Res; 2022 Mar; 42(3):1221-1227. PubMed ID: 35220212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
    Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
    Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread expression of γ-glutamyl cyclotransferase suggests it is not a general tumor marker.
    Amano T; Eishi Y; Yamada T; Uchida K; Minegishi K; Tamura T; Kobayashi D; Hiroshi K; Suzuki T; Board PG
    J Histochem Cytochem; 2012 Jan; 60(1):76-86. PubMed ID: 22205682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ggct (γ-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
    He Z; Sun X; Wang S; Bai D; Zhao X; Han Y; Hao P; Liu XS
    Br J Haematol; 2021 Oct; 195(2):267-275. PubMed ID: 34409610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.
    Taniguchi K; Ii H; Kageyama S; Takagi H; Chano T; Kawauchi A; Nakata S
    Biochem Biophys Res Commun; 2019 Sep; 517(2):238-243. PubMed ID: 31345573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer.
    Zhang W; Chen L; Xiang H; Hu C; Shi W; Dong P; Lv W
    BMC Biochem; 2016 Dec; 17(1):19. PubMed ID: 27905872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.
    Kageyama S; Hanada E; Ii H; Tomita K; Yoshiki T; Kawauchi A
    Biomed Res Int; 2015; 2015():345219. PubMed ID: 26339607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
    Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
    Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antitumor effect of HER2-directed CAR-T cells through blocking epithelial-mesenchymal transition in tumor cells.
    Zhang PF; Huang Y; Liang X; Li D; Jiang L; Yang X; Zhu M; Gou HF; Gong YL; Wei YQ; Li Q; Wang W
    FASEB J; 2020 Aug; 34(8):11185-11199. PubMed ID: 32645243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-glutamylcyclotransferase promotes the growth of human glioma cells by activating Notch-Akt signaling.
    Shen SH; Yu N; Liu XY; Tan GW; Wang ZX
    Biochem Biophys Res Commun; 2016 Mar; 471(4):616-20. PubMed ID: 26828272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy.
    Kageyama S; Ii H; Taniguchi K; Kubota S; Yoshida T; Isono T; Chano T; Yoshiya T; Ito K; Yoshiki T; Kawauchi A; Nakata S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle.
    Oakley AJ; Yamada T; Liu D; Coggan M; Clark AG; Board PG
    J Biol Chem; 2008 Aug; 283(32):22031-42. PubMed ID: 18515354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene.
    Wang X; Sun X; Mu L; Chen W
    Cancer Invest; 2019; 37(3):134-143. PubMed ID: 30961403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
    Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
    Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.